| Female (n = 2284) | Male (n = 606) | Total (N = 2890) |
---|---|---|---|
Self-reported change | Â | Â | Â |
 Much worse | 59 (2.6%) | 11 (1.8%) | 70 (2.4%) |
 A little worse | 85 (3.7%) | 28 (4.6%) | 113 (3.9%) |
 No change | 465 (20.4%) | 161 (26.6%) | 626 (21.7%) |
 A little better | 970 (42.5%) | 246 (40.6%) | 1216 (42.1%) |
 Much better | 705 (30.9%) | 160 (26.4%) | 865 (29.9%) |
Age at signup | Â | Â | Â |
 Mean (SD) | 38.1 (13.5) | 43.8 (13.5) | 39.3 (13.7) |
 Range | 16.4–79.9 | 17.0–77.9 | 16.4–79.9 |
Age during therapy | Â | Â | Â |
 Mean (SD) | 37.1 (13.2) | 42.5 (13.2) | 38.3 (13.4) |
 Range | 18.0–79.0 | 18.0–78.0 | 18.0–79.0 |
Ethnicity | Â | Â | Â |
 Arab | 2 (0.1%) | 0 (0.0%) | 2 (0.1%) |
 Asian or asian british | 18 (0.8%) | 9 (1.5%) | 27 (0.9%) |
 Black or black british | 8 (0.4%) | 1 (0.2%) | 9 (0.3%) |
 Mixed | 64 (2.8%) | 7 (1.2%) | 71 (2.5%) |
 Other | 16 (0.7%) | 10 (1.7%) | 26 (0.9%) |
 White | 2172 (95.3%) | 578 (95.5%) | 2750 (95.3%) |
 Missing data | 4 | 1 | 5 |
University degree | Â | Â | Â |
 No | 804 (35.8%) | 232 (39.1%) | 1036 (36.5%) |
 Yes | 1443 (64.2%) | 361 (60.9%) | 1804 (63.5%) |
 Missing data | 37 | 13 | 50 |
Age of onset | Â | Â | Â |
 Mean (SD) | 18.0 (8.7) | 22.1 (11.6) | 18.9 (9.5) |
 Range | 5.0–61.0 | 5.0–61.0 | 5.0–61.0 |
 Missing data | 136 | 59 | 195 |
Number of episodes | Â | Â | Â |
 Mean (SD) | 9.0 (3.7) | 9.4 (3.7) | 9.1 (3.7) |
 Range | 1.0–13.0 | 1.0–13.0 | 1.0–13.0 |
 Missing data | 548 | 147 | 695 |
Number of comorbidities | Â | Â | Â |
 Mean (SD) | 1.4 (1.3) | 1.3 (1.3) | 1.4 (1.3) |
 Range | 0.0–6.0 | 0.0–5.0 | 0.0–6.0 |
Personality disorder score | Â | Â | Â |
 Mean (SD) | 8.1 (3.5) | 8.0 (3.6) | 8.1 (3.5) |
 Range | 0.0–23.0 | 0.0–23.0 | 0.0–23.0 |
 Missing data | 1 | 0 | 1 |
First therapy | Â | Â | Â |
 No | 1989 (87.5%) | 510 (84.4%) | 2499 (86.9%) |
 Yes | 284 (12.5%) | 94 (15.6%) | 378 (13.1%) |
 Missing data | 11 | 2 | 13 |
Years since therapy at followup | Â | Â | Â |
 Mean (SD) | 2.4 (2.4) | 2.8 (2.7) | 2.5 (2.5) |
 Range | 0.0–10.0 | 0.0–10.0 | 0.0–10.0 |
Main diagnosis | Â | Â | Â |
 Major depressive disorder | 1329 (58.2%) | 382 (63.0%) | 1711 (59.2%) |
 Generalised anxiety disorder | 754 (33.0%) | 169 (27.9%) | 923 (31.9%) |
 Phobia (various) | 42 (1.8%) | 0 (0.0%) | 42 (1.5%) |
 Social anxiety disorder | 102 (4.5%) | 40 (6.6%) | 142 (4.9%) |
 Panic disorder | 57 (2.5%) | 15 (2.5%) | 72 (2.5%) |
Therapy type | Â | Â | Â |
 One-to-one CBT | 949 (41.5%) | 262 (43.2%) | 1211 (41.9%) |
 One-to-one counselling | 1199 (52.5%) | 284 (46.9%) | 1483 (51.3%) |
 Group CBT | 114 (5.0%) | 48 (7.9%) | 162 (5.6%) |
 Group counselling | 22 (1.0%) | 12 (2.0%) | 34 (1.2%) |
Concurrent medications | Â | Â | Â |
 No | 514 (22.6%) | 151 (25.3%) | 665 (23.2%) |
 Yes | 1759 (77.4%) | 447 (74.7%) | 2206 (76.8%) |
 Missing data | 11 | 8 | 19 |
Regular therapeutic activity | Â | Â | Â |
 No | 572 (25.9%) | 218 (37.7%) | 790 (28.3%) |
 Yes | 1636 (74.1%) | 361 (62.3%) | 1997 (71.7%) |
 Missing data | 76 | 27 | 103 |